Overview

Stem Cells for Bronchopulmonary Dysplasia

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
0
Participant gender:
All
Summary
Very preterm infants are at high risk to develop to bronchopulmonary dysplasia (BPD) for the lack of effective measures to prevent or ameliorate this common and serious disorder. BPD remains a major cause of mortality and lifelong morbidity in preterm infants
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborators:
Children's Hospital of Chongqing Medical University
Chongqing Maternal and Child Health Hospital
Criteria
Inclusion Criteria:

- diagnosed with BPD

Exclusion Criteria:

- parents' rejection